- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00425139
Evaluation of a Video Game for Adolescents and Young Adults With Cancer
Multi-site Evaluation of a Video Game for Adolescents and Young Adults With Cancer
Studie Overzicht
Gedetailleerde beschrijving
POPULATION: Approximately 340 patients will be enrolled in this study. Patients will be 13 to 29 years of age with any cancer (original diagnosis or relapse), currently receiving treatment and expected to be on treatment for at least 4 - 6 months following Baseline assessment, and able to communicate effectively in English, Spanish, or French. Approximately 170 patients will be enrolled in each of the two treatment groups. Each group will receive either the "Re-Mission" video game and a popular interactive video game, or just the popular interactive video game.
DESIGN: This is a multi-center, randomized trial, with patients randomized to one of two groups. One group (50% of patients) will receive the active intervention, which is the psycho-educational video game module called Re-Mission and a popular video game (hereafter "RE-MISSION") and another group (50 % of patients) will be in a game control group and receive a popular video game only (hereafter "GAME CONTROL. The games in the RE-MISSION and GAME CONTROL groups are delivered on identical mini, personal computers (hereafter "Mini-PC").
INTERVENTION: Each patient in the RE-MISSION group will be asked to play "Re-Mission" along with the popular video game for at least one hour a week for a period of ten to fourteen weeks. "Re-Mission" presents a 3-D environment in which the player can manipulate a humanoid character inside the virtual body of a patient with cancer. Game-play consists of guiding the character to destroy cancer cells and other "enemies" in the body (e.g., bacteria) while avoiding injury or weakness. During the process of playing the game and guiding the character through a series of missions, the player learns about chemotherapy and other medical treatments, health-promoting self-care behaviors, infections, and pain management. In addition, the game has also been designed to facilitate the patient's ability to share knowledge and concerns with others.
DURATION OF STUDY: 9 -12 months
Studietype
Inschrijving
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Victoria
-
Parkville, Victoria, Australië, 03052
- Royal Children's Hospital
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2T 5C7
- Calgary Alberta Children's Hospital
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 3Z5
- McMaster University
-
Ottawa, Ontario, Canada, K1H 8LI
- Children's Hospital of Eastern Ontario
-
-
Quebec
-
Montreal, Quebec, Canada, H3H 1P3
- McGill Univ Health Ctr - Montreal Children's Hospital
-
Montreal, Quebec, Canada, H3T 1C5
- Hôpital Ste-Justine
-
Ste-Foy, Quebec, Canada, G1V 4G2
- Centre Hospitalier Universitaire de Quebec
-
-
-
-
California
-
Duarte, California, Verenigde Staten, 91010
- City of Hope National Medical Center
-
Los Angeles, California, Verenigde Staten, 90027
- Los Angeles Children's Center for Cancer and Blood Disease
-
Orange, California, Verenigde Staten, 92868
- Children's Hospital of Orange County
-
Palo Alto, California, Verenigde Staten, 94304
- Lucile Packard Children's Hospital at Stanford
-
-
Florida
-
Fort Myers, Florida, Verenigde Staten, 33908
- Children's Hospital of SW Florida / Lee Memorial Health System
-
Jacksonville, Florida, Verenigde Staten, 32207
- Nemours Children's Clinic-Jacksonville
-
St. Petersburg, Florida, Verenigde Staten, 33701
- All Children's Hospital
-
Tampa, Florida, Verenigde Staten, 33607
- St. Joseph's Children's Hospital of Tampa
-
-
Hawaii
-
Honolulu, Hawaii, Verenigde Staten, 96826
- Kapiolani Medical Center
-
-
Louisiana
-
New Orleans, Louisiana, Verenigde Staten, 70118
- LSU Children's Hospital of New Orleans
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02115
- Dana-Farber Cancer Institute and Children's Hospital
-
-
Michigan
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- DeVos Children's Hospital
-
Grosse Pointe Woods, Michigan, Verenigde Staten, 48236
- St John Van Elslander Cancer Center
-
-
Minnesota
-
St. Paul, Minnesota, Verenigde Staten, 55404
- Children's Health Care - Minneapolis
-
-
Missouri
-
Kansas City, Missouri, Verenigde Staten, 64108
- Children's Mercy Hospital
-
St. Louis, Missouri, Verenigde Staten, 63110
- Washington University
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87131-0001
- Children's Hospital of New Mexico
-
-
New York
-
Rochester, New York, Verenigde Staten, 14642
- Golisano Children's Hospital, University of Rochester
-
-
Oklahoma
-
Tulsa, Oklahoma, Verenigde Staten, 74136
- Warren Clinic / Saint Francis Hospital
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97227
- Legacy Emanuel Children's Cancer Program
-
Portland, Oregon, Verenigde Staten, 97239
- Doernbecher Childrens Hospital - OHSU
-
-
Texas
-
Austin, Texas, Verenigde Staten, 78701-1096
- Children's Hospital of Austin
-
Corpus Christi, Texas, Verenigde Staten, 78411
- Driscoll Children's Hospital
-
Fort Worth, Texas, Verenigde Staten, 76104
- Cook Children's Medical Center
-
San Antonio, Texas, Verenigde Staten, 78207
- Christus Santa Rosa Children's Hospital
-
-
Virginia
-
Norfolk, Virginia, Verenigde Staten, 23507
- Children's Hospital of The King's Daughters
-
-
Washington
-
Spokane, Washington, Verenigde Staten, 99204
- Deaconess Medical Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Male or female patient 13 to 29 years of age with a cancer diagnosis.
- Patient who is currently receiving treatment and is expected to remain on treatment for at least 4 - 6 months.
Exclusion Criteria:
- Patient who has a history of seizures due to photosensitivity.
- Patient who has been determined by the investigator to be incapable of following the study schedule or study directions for any reason.
- Patient who can not communicate effectively with study personnel in English, Spanish, or French.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
|---|
|
Kwaliteit van het leven
|
|
Aanhankelijkheid
|
|
Zelfeffectiviteit
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Pamela M Kato, HopeLab Foundation
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- HL-04-001
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .